Angiodynamics Inc
ANGONasdaqCIK 1275187HealthcareFiscal year ends May 31
Reports and events: 312 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-07-1207:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-034123 |
| 2023-06-1416:39 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001140361-23-029854 |
| 2023-06-0817:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-028985 |
| 2023-06-0207:00 ET | 8-K | 8.01 Other events | 0001140361-23-027896 |
| 2023-04-1707:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-018553 |
| 2023-03-3114:32 ET | 10-Q | Quarterly reportPeriod 2023-02-28 | 0001628280-23-010093 |
| 2023-03-3007:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-23-000149 |
| 2023-03-0607:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-23-000145 |
| 2023-02-2712:14 ET | 8-K | 8.01 Other events | 0000914121-23-000135 |
| 2023-01-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-23-000011 |
| 2023-01-0616:55 ET | 10-Q | Quarterly reportPeriod 2022-11-30 | 0001275187-23-000005 |
| 2023-01-0507:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-23-000003 |
| 2022-11-3007:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-043590 |
| 2022-11-2308:33 ET | 8-K | 8.01 Other events | 0001140361-22-042873 |
| 2022-11-0416:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000914121-22-004127 |
| 2022-10-1116:27 ET | 10-Q | Quarterly reportPeriod 2022-08-31 | 0001275187-22-000026 |
| 2022-10-0615:46 ET | 8-K | 8.01 Other events | 0000914121-22-004106 |
| 2022-10-0607:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-22-004104 |
| 2022-09-2210:16 ET | DEF 14A | Proxy statementPeriod 2022-05-31 | 0001275187-22-000021 |
| 2022-08-3117:26 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000914121-22-004083 |
| 2022-08-1007:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-22-004074 |
| 2022-07-2215:01 ET | 10-K | Annual reportPeriod 2022-05-31 | 0001275187-22-000017 |
| 2022-07-1208:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-22-004052 |
| 2022-04-0716:14 ET | 10-Q | Quarterly reportPeriod 2022-02-28 | 0001275187-22-000010 |
| 2022-04-0707:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-22-002826 |
| 2022-01-1007:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-22-000132 |
| 2022-01-0712:26 ET | 10-Q | Quarterly reportPeriod 2021-11-30 | 0001275187-22-000005 |
| 2022-01-0607:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-22-000084 |
| 2021-12-0608:00 ET | 8-K | 8.01 Other events | 0000914121-21-007590 |
| 2021-11-0316:31 ET | 8-K | 5.07 Shareholder vote results | 0000914121-21-007073 |
| 2021-09-3016:37 ET | 10-Q | Quarterly reportPeriod 2021-08-31 | 0001275187-21-000023 |
| 2021-09-3007:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-006377 |
| 2021-09-2212:27 ET | DEF 14A | Proxy statementPeriod 2021-05-31 | 0001275187-21-000017 |
| 2021-07-2713:54 ET | 10-K | Annual reportPeriod 2021-05-31 | 0001275187-21-000013 |
| 2021-07-1308:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-004918 |
| 2021-07-1306:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000914121-21-004916 |
| 2021-05-2506:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-003853 |
| 2021-04-1206:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-002530 |
| 2021-03-3112:09 ET | 10-Q | Quarterly reportPeriod 2021-02-28 | 0001275187-21-000008 |
| 2021-03-3007:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-001868 |
| 2021-03-0908:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-001492 |
| 2021-02-0316:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000914121-21-000581 |
| 2021-01-1114:32 ET | 8-K | 7.01 Regulation FD disclosure | 0000914121-21-000070 |
| 2021-01-0812:06 ET | 10-Q | Quarterly reportPeriod 2020-11-30 | 0001275187-21-000005 |
| 2021-01-0716:15 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-000060 |
| 2021-01-0707:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-21-000046 |
| 2020-11-1906:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-20-004172 |
| 2020-10-1508:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000914121-20-003700 |
| 2020-10-0716:18 ET | 10-Q | Quarterly reportPeriod 2020-08-31 | 0001275187-20-000034 |
| 2020-09-2907:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914121-20-003469 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.